Atrás
Precio Immuron Limited (IMRN)
Gráfico del Precio de Acciones IMRN
IMRN Ganando
Immuron Limited
$0.79
4.8%
$0.03
Hasta hoy:Feb 10, 11:51:08 GMT-5
Earnings FAQ
¿Cómo se comparó el EPS reciente de IMRN con las expectativas?
¿Cómo fue el desempeño de los ingresos de Immuron Limited IMRN en el último trimestre?
¿Cuál es la estimación de ingresos para Immuron Limited?
¿Cuál es la puntuación de calidad de ganancias de Immuron Limited?
¿Cuándo informa Immuron Limited sus ganancias?
¿Cuáles son las ganancias esperadas de Immuron Limited?
¿Superó Immuron Limited las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0.7539
Precio de apertura
$0.78
Rango del día
$0.78 - $0.8209
Rango de 52 semanas
$0.677 - $2.39
Volumen
4.6K
Volumen promedio
470.7K
EPS (TTM)
-0.63
Rendimiento de dividendos
--
Cap. de mercado
$6.3M
¿Qué es Immuron Limited?
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved